Skip to main content
Fig. 3 | Pediatric Rheumatology

Fig. 3

From: Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report

Fig. 3

Immunoprecipitation-Western blotting of anti-SAE autoantibody. Lane1: molecular weight marker, lane2: serum from the patient, lane3: positive control (serum with anti-small ubiquitin-like modifier 1 activating enzyme (SAE) autoantibody), lane4–6: negative controls (anti-transcriptional intermediary factor-1 (TIF1) gamma autoantibody; Lane4, anti-melanoma differentiation-associated gene 5 (MDA5) autoantibody; Lane5, anti-nuclear matrix protein 2(NXP2) autoantibody; Lane6)

Back to article page